Susan Palsbo
Eugene, Oregon, 97405, United States
NCT Number: NCT00919906
This study will assess whether a computer haptic peripheral device programmed to provide repetitive motion training is as effective as the same repetitive motion training provided by a human being.
Looking for future studies?
Notify Me5 year–19 year
All sexes
Interventional
Phase 1 / Phase 2
Eugene, Oregon, 97405, United States
This study builds on a large body of neurological research that uses robot-guided repetitive motion training to induce neuroplasticity and improvements in upper extremity motor skills in adults and children. This research study is looking at handwriting, a fine-motor task that is used daily.
In our study, we want to see if 3-dimensional robotic-assisted repetitive motion training can be a safe and effective intervention for school-age children with fine motor deficits arising from several different impairment origins. Our research construct is: Legible handwriting = function of (tactile feedback, visual feedback, duration, and fine-motor control).
Independent variables:
Dependent variable:
The robotic device is an affordable (<$200) computer haptic (the Falcon(R)) that currently is approved by the FCC for home and office. It is *not* approved for medical use. This is an investigational, nonsignificant risk device.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Twenty 20-minute sessions of the Handwriting Without Tears(R) instructional handwriting program, with substitution of hand-over-hand or self-generated repetitive motion writing by computer guided repetitive motion.
Other names: My Scrivener, Falcon, by Novint Technologies, Handwriting Without Tears
Time frame: after 20 interventions
Time frame: after 20 interventions
Time frame: after 5, 10, 15, 20 interventions
Time frame: after 20 interventions
Obslap Research LLC
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02028247
Anxiety Disorders, Anxiety, Separation
St. Petersburg, Florida, United States
View Trial DetailsNCT00902798
Asperger Syndrome, Asperger's Syndrome
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT00496210
Asperger Syndrome, Asperger's Syndrome
Bethesda, Maryland, United States
View Trial DetailsNCT01919970
Anxiety Disorders, Anxiety, Separation
St. Petersburg, Florida, United States
View Trial Details